Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aneurysmal bone cyst (ABC) is a locally destructive benign tumour-like condition of the bones with blood-filled cystic cavities. The talus is an extremely rare site for an ABC, with <20 reported cases till 2012 based on a PubMed database search. Aneurysmal bone cyst recurrence in the talus after curettage and bone grafting is extremely rare. To the best of our knowledge, no detailed reports of resection and adjuvant therapy with artificial bone packing of recurrent ABC of the talus have been published. We report a case of ABC in the talus of a 9-year-old boy. As the initial surgery consisted of only lesion resection and artificial bone (beta-tricalcium phosphate [TCP]) packing, local recurrence was diagnosed. Reoperation was performed 5 months after the initial surgery. The recurrent lesion was resected using a curette, and the bone cavity septum was shaved with a high-speed burr. Phenol-ethanol ablation was used as an adjuvant with artificial bone (beta-TCP) packing to prevent recurrence. No local recurrence was observed 36 months after the reoperation. This extremely rare case of resection and adjuvant therapy with artificial bone packing of recurrent ABC of the talus highlights the need for careful observation to assess the progression of ankle joint osteoarthrosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12404704PMC
http://dx.doi.org/10.1093/bjrcr/uaaf041DOI Listing

Publication Analysis

Top Keywords

aneurysmal bone
8
bone cyst
8
cyst talus
4
talus case
4
case report
4
report local
4
local recurrence
4
recurrence treated
4
treated adjuvant
4
adjuvant therapy
4

Similar Publications

This case report is focused on a patient (a 32-year-old previously healthy man) with a femoral bone tissue tumor. The case underscores the diagnostic complexity of Telangiectatic Osteosarcoma (TOS) with Aneurysmal Bone Cystic (ABC) lesion and the importance of maintaining special immunohistochemical markers for differential diagnosis between low-grade osteosarcoma, primary ABC, and suspected TOS, which is a true mimicker of ABC. On the other hand, this presentation describes some molecular rearrangements seen in ABC.

View Article and Find Full Text PDF

Purpose: Teleangiectatic osteosarcoma is a histologic subtype of osteosarcoma that can mimic aneurysmal bone cysts and has so far been incompletely characterized.

Patients And Methods: We used the database of the Cooperative Osteosarcoma Study Group COSS (patient-registration 1980-2019) to better understand this rare histologic variant.

Results: 223 eligible patients were identified, 164 having reference pathology (median age 15.

View Article and Find Full Text PDF

Sequential treatment for diabetic foot ulcers in aortic dissection patients: a case report.

Front Endocrinol (Lausanne)

September 2025

Department of Orthopedics, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Diabetic foot ulcers (DFUs) represent a prevalent complication of diabetes, with a lifetime risk ranging from 15% to 25% among diabetic patients. Research indicates that anticoagulation plays a crucial role in the management of newly diagnosed cases of diabetic lower extremity atherosclerotic obliterative disease. However, in the present case, the patient developed dry gangrene in both toes after receiving vasodilator drugs during an emergency intervention for sudden aortic dissection.

View Article and Find Full Text PDF

Aneurysmal bone cyst (ABC) is a locally destructive benign tumour-like condition of the bones with blood-filled cystic cavities. The talus is an extremely rare site for an ABC, with <20 reported cases till 2012 based on a PubMed database search. Aneurysmal bone cyst recurrence in the talus after curettage and bone grafting is extremely rare.

View Article and Find Full Text PDF

Human sclerostin-inspired short peptides reverse osteoporosis and suppress joint degeneration in osteoarthritis via opposing Wnt pathways.

Biomed Pharmacother

September 2025

Division of Endocrinology and Centre for Research in ASTHI, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address:

Sclerostin, a key regulator of Wnt/β-catenin signaling, exhibits dual therapeutic potential in bone disorders: its inhibition promotes bone formation in osteoporosis, while its mimicry suppresses aberrant bone growth in osteoarthritis (OA). Using structural insights from NMR studies, we identified two sclerostin-derived peptides: SC-1 (an 18-mer) from loop 2, and SC-3 (a 14-mer) from loop 3. Molecular modeling showed that SC-1 binds to the first ectodomain of LRP6, potentially displacing sclerostin through competitive inhibition to activate Wnt signaling.

View Article and Find Full Text PDF